| Literature DB >> 31742338 |
Michel Adamina1,2, Stefanos Bonovas3,4, Tim Raine5, Antonino Spinelli6, Janindra Warusavitarne7, Alessandro Armuzzi8, Oliver Bachmann9, Palle Bager10, Livia Biancone11, Bernd Bokemeyer12, Peter Bossuyt13, Johan Burisch14, Paul Collins15, Glen Doherty16, Alaa El-Hussuna17, Pierre Ellul18, Gionata Fiorino3,4, Cornelia Frei-Lanter19, Federica Furfaro4, Christian Gingert20, Paolo Gionchetti21, Javier P Gisbert22, Fernando Gomollon23, Marien González Lorenzo3, Hannah Gordon24, Tibor Hlavaty25, Pascal Juillerat26, Konstantinos Katsanos27, Uri Kopylov28, Eduards Krustins29, Torsten Kucharzik30, Theodore Lytras31, Christian Maaser32, Fernando Magro33, John Kenneth Marshall34, Pär Myrelid35, Gianluca Pellino36, Isadora Rosa37, Joao Sabino38, Edoardo Savarino39, Laurents Stassen40, Joana Torres41, Mathieu Uzzan42, Stephan Vavricka43, Bram Verstockt44, Oded Zmora45.
Abstract
This article is the second in a series of two publications relating to the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's disease. The first article covers medical management; the present article addresses surgical management, including preoperative aspects and drug management before surgery. It also provides technical advice for a variety of common clinical situations. Both articles together represent the evidence-based recommendations of the ECCO for Crohn's disease and an update of previous guidelines.Entities:
Keywords: Crohn’s disease; inflammatory bowel disease [IBD]; surgery
Year: 2020 PMID： 31742338 DOI： 10.1093/ecco-jcc/jjz187
Source DB: PubMed Journal: J Crohns Colitis ISSN： 1873-9946 Impact factor: 9.071